Christopher C. Richard's Insider Trades & SAST Disclosures

Christopher C. Richard's most recent trade in Lexaria Bioscience Corp was a trade of 27,172 common shares done at an average price of $2.5 . Disclosure was reported to the exchange on Dec. 2, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lexaria Bioscience Corp
Christopher Richard C. Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.47 per share. 02 Dec 2024 27,172 50,000 - 2.5 67,175 common shares
Lexaria Bioscience Corp
Christopher C. Richard Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.24 per share. 02 Dec 2024 22,828 22,828 - 2.2 51,217 common shares
InVivo Therapeutics Holdin...
Richard C. Christopher Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2022 20,800 20,800 - - Stock Option (right to buy)
InVivo Therapeutics Holdin...
Richard C. Christopher CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 75,000 75,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades